Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 5, 2007, Pages 697-704

  Rönkkö, Seppo ^a   Rekonen, Petri ^a,b   Kaarniranta, Kai ^a,b   Puustjärvi, Tuomo ^b   Teräsvirta, Markku ^a,b   Uusitalo, Hannu ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Glaucoma; Inhibitors; Matrix metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MONOCLONAL ANTIBODY; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ADULT; AGED; ANTERIOR EYE CHAMBER ANGLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; ENZYME BLOOD LEVEL; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCHLEMM CANAL; SCLERECTOMY; TRABECULAR MESHWORK;

AGED; AGED, 80 AND OVER; ANTERIOR CHAMBER; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASES; TRABECULAR MESHWORK;

EID: 34250696153     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0440-1     Document Type: Article

References (37)

1. Aasved H (1971) The frequency of optic nerve damage and surgical treatment in chronic simple glaucoma and capsular glaucoma. Acta Ophthalmol 49(4):589-600
2. Alexander JP, Samples JR, Van Buskirk EM, Acott TS (1991) Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 32(1):172-180
3. Coleman AL (1999) Glaucoma. Lancet 354(9192):1803-1810
4. Forsius H (1979) Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos, and Russians. Trans Ophthalmol Soc UK 99(2):296-298
5. Futa R, Shimizu T, Furuyoshi N, Nishiyama M, Hagihara O (1992) Clinical features of capsular glaucoma in comparison with primary open-angle glaucoma in Japan. Acta Ophthalmol 70(2):214-219
6. Gross J, Lapiere CM (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 48:1014-1022
7. Ho SL, Dogar GF, Wang J, Crean J, Wu QD, Oliver N, Weitz S, Murray A, Cleary PE, O'Brien C (2005) Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol 89(2):169-173
8. John A, Tuszynski G (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7(1):14-23
9. Kerrigan JJ, Mansell JP, Sandy JR (2000) Matrix turnover. J Orthod 27(3):227-233
10. Konstas AG, Stewart WC, Stroman GA, Sine CS (1997) Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma. Ophthalmic Surg Lasers 28(2):111-117
11. Krause U, Helve J, Forsius H (1973) Pseudoexfoliation of the lens capsule and liberation of iris pigment. Acta Ophthalmol (Copenh) 51(1):39-46
12. Krause U, Alanko HI, Kärnä J, Miettinen R, Larmi T, Jaanio E, Ollila OI, Takala J (1988) Prevalence of exfoliation syndrome in Finland. Acta Ophthalmol Suppl (Copenh) 66(184):120-122
13. Lahm A, Uhl M, Lehr HA, Ihling C, Kreuz PC, Haberstroh J (2004) Photoshop-based image analysis of canine articular cartilage after subchondral damage. Arch Orthop Trauma Surg 124(7):431-436
14. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM (1997) Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45(11):1559-1565
15. Lindblom B, Thorburn W (1982) Prevalence of visual field defects due to capsular and simple glaucoma in Halsingland, Sweden. Acta Ophthalmol (Copenh) 60(3):353-361
16. Lindblom B, Thorburn W (1984) Functional damage at diagnosis of primary open angle glaucoma. Acta Ophthalmol (Copenh) 62(2):223-229
17. Liotta LA, Tryggvason K, Garbisa S, Robey PG, Abe S (1981) Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochemistry 20(1):100-104
18. Lütjen-Drecoll E (1998) Functional morphology of the trabecular meshwork in primate eyes. Prog Ret Eye Res 18(1):91-119
19. Maatta M, Tervahartiala T, Harju M, Airaksinen J, Autio-Harmainen H, Sorsa T (2005) Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome and exfoliation glaucoma. J Glaucoma 14(1):64-69
20. McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol 13(5):534-540
21. Mohammed FF, Smookler DS, Khokha R (2003) Metalloproteinases, inflammation, and rheumatoid arthritis. Ann Rheum Dis 62(Suppl II):iI43-ii47
22. Murphy G, Ward R, Hembry RM, Reynolds JJ, Kuhn K, Tryggvason K (1989) Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J 258(2):463-472
23. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274(31):21491-21494
24. Okada Y, Nagase H, Harris ED Jr (1986) A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 261(30):14245-14255
25. Pang IH, Hellberg PE, Fleenor DL, Jacobson N, Clark AF (2003) Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 44(8):3485-3493
26. Ritch R, Schlötzer-Schrehardt U (2001) Exfoliation syndrome. Surv Ophthalmol 45(4):265-315
27. Ritch R, Schlötzer-Schrehardt U, Konstas AGP (2003) Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res 22(3):253-275
28. Samples JR, Alexander JP, Acott TS (1993) Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci 34(12):3386-3395
29. Schlötzer-Schrehardt U, Lommantzsch J, Kühle M, Konstans AGP, Naumann GOH (2003) Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 44(3):1117-1125
30. Seiki M (2003) Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion. Cancer Lett 194(1):1-11
31. Sivak JM, Fini ME (2002) MMPs in the eye: Emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 21(1):1-14
32. Szekanecz Z, Halloran MM, Haskell CJ, Shah MR, Polverini PJ, Koch AE (1999) Mediators of angiogenesis: The role of cellular adhesion molecules. Trends Glycosci Glycotechnol 11(58):73-93
33. Tarkkanen A (1962) Pseudoexfoliation of the lens capsule. A clinical study of 418 patients with special reference to glaucoma, cataract, and changes of the vitreous. Acta Ophthalmol (Copenh) Suppl 71:1-98
34. Tsuruda TT, Costello-Boerrigter LC, Burnett JC Jr (2004) Matrix metalloproteinases: Pathways of induction by bioactive molecules. Heart Fail Rev 9(1):53-61
35. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92(8):827-839
36. Vu TH, Werb Z (2000) Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 14(17):2123-2133
37. Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363(9422):1711-1720